image
Healthcare - Biotechnology - NASDAQ - CH
$ 3.79
-1.45 %
$ 140 M
Market Cap
-2.12
P/E
INCOME STATEMENT
4.97 M REVENUE
-29.38%
-61.2 M OPERATING INCOME
-0.18%
-54 M NET INCOME
12.81%
EFFICIENCY
Earnings Waterfall Molecular Partners AG
image
Revenue 4.97 M
Cost Of Revenue 0
Gross Profit 4.97 M
Operating Expenses 66.2 M
Operating Income -61.2 M
Other Expenses -7.17 M
Net Income -54 M
10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)5m05m(66m)(61m)7m(54m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 5.0 7.0 189.6 9.3 9.3 20.4 10.4 20.0 23.0 29.1 26.6 32.4
GROSS PROFIT
Cost Of Revenue 0 47.8 50.7 55.7 56.1 43.5 15.6 17.8 14.6 1.2 0.2 1.2
Gross Profit 5.0 (40.8) 138.8 (46.4) (46.7) (23.1) (5.2) 2.2 8.5 28.0 26.5 31.2
OPERATING INCOME
Operating Expenses 66.2 20.3 72.9 72.7 67.7 57.0 47.8 45.9 42.5 31.3 24.8 25.3
Selling, General and Administrative Expenses 17.2 19.0 21.8 16.9 11.0 13.2 9.5 8.3 7.2 6.2 4.9 3.6
Research and Development Expenses 48.6 48.8 50.7 55.7 56.1 43.5 38.2 37.5 35.2 23.9 18.8 20.8
Operating Income (61.2) (61.1) 116.6 (63.4) (58.3) (36.7) (37.4) (25.8) (19.5) (2.2) 1.8 7.1
PRE-TAX INCOME
Interest Income Expense 25 K 49 K 0.6 0.5 0.3 27 K 0.1 0.2 89 K 216 853 8.29 K
Total Other Income 7.2 (0.9) 1.2 (0.4) (4.4) 0.4 0.4 0.4 0.9 2.1 (4.1) 24.9 K
Pre-Tax Income (54.0) (62.0) 117.9 (63.8) (62.8) (36.3) (37.0) (25.4) (18.6) (0.1) (2.3) 7.1
NET INCOME
Tax Provision 2 K 0 (0.7) 2 K 11 K 17 K (0.2) 1 K (0.6) (1.8) 4.5 0.2
Net Income (54.0) (62.0) 117.9 (63.8) (62.8) (36.3) (37.0) (25.4) (18.6) (0.1) (2.3) 7.1
EPS 1.59 1.89 3.63 2.06 2.51 1.69 1.75 1.22 0.91 0.0076 0.15 0.37